Starfos

Project

Screening of mutations in the non-duplicated region of the PKD1 gene from families with autosomal dominant polycystic kidney disease (NE7633)

Analysis of mutations in non-duplicated region of the PKD1 gene in selected families with ADPKD by screening methods (SSCP,HA,DGGE) and following sequencing of positive fragments.......

EB - Genetika a molekulární biologie

2003 - 2005

•

3 439 tis. Kč

•

3 364 tis. Kč

•

MZ

Project

Screening of mutations in the PKD2 gene from families with autosomal dominant polycystic kidney disease. (NE5996)

Analysis of mutations in PKD2 gene in selected families with ADPKD by screening methods (SSCP,HA,DGGE) and following sequenation of positive fragments. Analysis of mutations in PKD2 gene is the only temporary available meth...

FE - Ostatní obory vnitřního lékařství

2000 - 2002

•

3 422 tis. Kč

•

3 420 tis. Kč

•

MZ

Project

Screening of mutations in the duplicated region of the PKD1 gene from families with autosomal dominant polycystic kidney disease (NR9427)

Analysis of mutations in duplicated region of the PKD1 gene in selected families with ADPKD by LR-PCR , screening methods (SSCP,HA,DGGE) and following sequencing of positive fragments.......

EB - Genetika a molekulární biologie

2007 - 2010

•

4 789 tis. Kč

•

4 669 tis. Kč

•

MZ

Project

Mutational analysis of BRCA1 and BRCA2 genes in hereditary forms of breast and ovarian cancer. Clinical application in the South Moravian region. (NC5561)

Molecular-genetic testing of mutations in BRCA1 and BRCA2 genes by some of the screening methods (SSCP,HA,CDCE,PTT) Sequencing analysis of PCR fragments with detected mutations by screening methods.......

FD - Onkologie a hematologie

1999 - 2001

•

3 675 tis. Kč

•

3 675 tis. Kč

•

MZ

Project

Role of dominant susceptibility genes in breast tumorigenesis - RNA-based analyses (NR9051)

with allelicdeletions will be further screened for mutations. Deleterious mutations and other in brest cancer tumorigenesis. BRCA1 a BRCA2 genes will be screened for rearrangements and splice variants. Mutatio...

FD - Onkologie a hematologie

2006 - 2008

•

2 936 tis. Kč

•

2 808 tis. Kč

•

MZ

Project

Frequency of the G985 MACD mutation in the Czech population and in sudden infant death syndrome. (IZ4379)

To introduce the direct DNA disgnostics of G985 mutation from a dry blood spots of screened newborns,to establish the frequency of the mutation mentioned in our population. To determine the percentage with which G985 mu...

FG - Pediatrie

1997 - 1999

•

3 102 tis. Kč

•

2 032 tis. Kč

•

MZ

Project

Molecular analysis of the APC and MYH genes in families affected with familial adenomatous polyposis or multiple adenomas (NR8103)

of families with no demonstrable germline APC mutation. Analysis of invisible germline APC mutations and of germline MYH mutations. Mutation analysis using real-time quantitative PCR,analysis of single nucleotide ...

FD - Onkologie a hematologie

2004 - 2006

•

2 846 tis. Kč

•

2 810 tis. Kč

•

MZ

Project

Screening and mutational analysis of ligands of the proteinase of HIV using phage display technology. (IZ3272)

FN - Epidemiologie, infekční nemoci a klinická imunologie

1995 - 1998

•

1 272 tis. Kč

•

1 272 tis. Kč

•

MZ

Project

Screening of familial ligand-defective apo B-100 from dried blood spots of newborns. (IZ4382)

To determine the frequency of FDB (mutation R3500Q in apo B gene) in Czech population. To identify affected individuals from blood spots within newborns screening. To suggest a complex of therapeutio-preventive measures with respect...

FA - Kardiovaskulární nemoci včetně kardiochirurgie

1997 - 1999

•

4 789 tis. Kč

•

3 001 tis. Kč

•

MZ

Project

Frequency and types of de novo germline mutations in BRCA1/2 genes in the group of women younger than40 with sporadic breast/ovarian cancer without positive family history. (NC6396)

Using molecular genetic analysis of BRCA 1 and 2 genes frequency and character of germ-line mutations in women under 40 years of age and without family history presenting with early sporadic breast/ovarian cancer. Germ-line mutations

FD - Onkologie a hematologie

2000 - 2002

•

2 729 tis. Kč

•

2 729 tis. Kč

•

MZ

What are you looking for?

Quick search

Smart search

Filters

Screening of mutations in the non-duplicated region of the PKD1 gene from families with autosomal dominant polycystic kidney disease (NE7633)

Screening of mutations in the PKD2 gene from families with autosomal dominant polycystic kidney disease. (NE5996)

Screening of mutations in the duplicated region of the PKD1 gene from families with autosomal dominant polycystic kidney disease (NR9427)

Mutational analysis of BRCA1 and BRCA2 genes in hereditary forms of breast and ovarian cancer. Clinical application in the South Moravian region. (NC5561)

Role of dominant susceptibility genes in breast tumorigenesis - RNA-based analyses (NR9051)

Frequency of the G985 MACD mutation in the Czech population and in sudden infant death syndrome. (IZ4379)

Molecular analysis of the APC and MYH genes in families affected with familial adenomatous polyposis or multiple adenomas (NR8103)

Screening and mutational analysis of ligands of the proteinase of HIV using phage display technology. (IZ3272)

Screening of familial ligand-defective apo B-100 from dried blood spots of newborns. (IZ4382)

Frequency and types of de novo germline mutations in BRCA1/2 genes in the group of women younger than40 with sporadic breast/ovarian cancer without positive family history. (NC6396)